We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q4 Earnings
Read MoreHide Full Article
The upcoming report from Cigna (CI - Free Report) is expected to reveal quarterly earnings of $7.87 per share, indicating an increase of 18.5% compared to the year-ago period. Analysts forecast revenues of $69.93 billion, representing an increase of 6.5% year over year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Cigna metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Revenues- Net investment income' will reach $262.89 million. The estimate indicates a change of -5.1% from the prior-year quarter.
The consensus among analysts is that 'Revenues- Cigna Healthcare' will reach $10.92 billion. The estimate points to a change of -17.9% from the year-ago quarter.
Analysts forecast 'Revenues- Evernorth Health Services' to reach $59.19 billion. The estimate points to a change of +10.1% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenues- Pharmacy' of $56.03 billion. The estimate points to a change of +12.2% from the year-ago quarter.
The combined assessment of analysts suggests that 'Revenues- Fees and Other' will likely reach $4.40 billion. The estimate indicates a year-over-year change of +12.1%.
The average prediction of analysts places 'Revenues- Premiums' at $8.94 billion. The estimate indicates a year-over-year change of -22.2%.
Analysts predict that the 'Revenues- Evernorth Health Services- Net investment income' will reach $50.21 million. The estimate points to a change of +28.8% from the year-ago quarter.
Based on the collective assessment of analysts, 'Premiums- Cigna Healthcare- International Health' should arrive at $1.03 billion. The estimate points to a change of +9.6% from the year-ago quarter.
Analysts' assessment points toward 'Services (Fees)- Evernorth Health Services' reaching $3.43 billion. The estimate indicates a year-over-year change of +11.4%.
The consensus estimate for 'Medical Care Ratio - Cigna Healthcare' stands at 87.2%. The estimate is in contrast to the year-ago figure of 87.9%.
According to the collective judgment of analysts, 'Healthcare Medical Customers - Administrative services only - U.S. Healthcare' should come in at 13.80 million. The estimate is in contrast to the year-ago figure of 13.65 million.
Analysts expect 'Medical Customers - Total' to come in at 18.09 million. Compared to the current estimate, the company reported 19.15 million in the same quarter of the previous year.
Over the past month, Cigna shares have recorded returns of -1.8% versus the Zacks S&P 500 composite's +0.7% change. Based on its Zacks Rank #3 (Hold), CI will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q4 Earnings
The upcoming report from Cigna (CI - Free Report) is expected to reveal quarterly earnings of $7.87 per share, indicating an increase of 18.5% compared to the year-ago period. Analysts forecast revenues of $69.93 billion, representing an increase of 6.5% year over year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Cigna metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Revenues- Net investment income' will reach $262.89 million. The estimate indicates a change of -5.1% from the prior-year quarter.
The consensus among analysts is that 'Revenues- Cigna Healthcare' will reach $10.92 billion. The estimate points to a change of -17.9% from the year-ago quarter.
Analysts forecast 'Revenues- Evernorth Health Services' to reach $59.19 billion. The estimate points to a change of +10.1% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenues- Pharmacy' of $56.03 billion. The estimate points to a change of +12.2% from the year-ago quarter.
The combined assessment of analysts suggests that 'Revenues- Fees and Other' will likely reach $4.40 billion. The estimate indicates a year-over-year change of +12.1%.
The average prediction of analysts places 'Revenues- Premiums' at $8.94 billion. The estimate indicates a year-over-year change of -22.2%.
Analysts predict that the 'Revenues- Evernorth Health Services- Net investment income' will reach $50.21 million. The estimate points to a change of +28.8% from the year-ago quarter.
Based on the collective assessment of analysts, 'Premiums- Cigna Healthcare- International Health' should arrive at $1.03 billion. The estimate points to a change of +9.6% from the year-ago quarter.
Analysts' assessment points toward 'Services (Fees)- Evernorth Health Services' reaching $3.43 billion. The estimate indicates a year-over-year change of +11.4%.
The consensus estimate for 'Medical Care Ratio - Cigna Healthcare' stands at 87.2%. The estimate is in contrast to the year-ago figure of 87.9%.
According to the collective judgment of analysts, 'Healthcare Medical Customers - Administrative services only - U.S. Healthcare' should come in at 13.80 million. The estimate is in contrast to the year-ago figure of 13.65 million.
Analysts expect 'Medical Customers - Total' to come in at 18.09 million. Compared to the current estimate, the company reported 19.15 million in the same quarter of the previous year.
View all Key Company Metrics for Cigna here>>>Over the past month, Cigna shares have recorded returns of -1.8% versus the Zacks S&P 500 composite's +0.7% change. Based on its Zacks Rank #3 (Hold), CI will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .